Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of mother-to-child transmission of HIV-1 without nucleoside analogues
2006-006200-11Phase 2Active
- Sponsor
- ANRS
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ANRS. Primary endpoint: Virologic response at 8 weeks of treatment. Started Jan 2007; status: active.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006200-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006200-11.